Table 2 Most common number of post-CR tests over 12 months after the prognostic MRD test
Adults with Ph − disease | Adults with Ph + disease | |||||||
|---|---|---|---|---|---|---|---|---|
MRD− | MRD+ | MRD− | MRD+ | |||||
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | |
France | 3 (3) | 3 (2–3) | 3 (2) | 2 (2–3) | 4 (5) | 3 (2–4) | 3 (4) | 2 (2–3) |
Germany | 5 (5) | 3 (2–4) | 4 (4) | 2 (2–6) | 5 (5) | 3 (2–4) | 4 (5) | 3 (2–5) |
Italy | 6 (6) | 4 (3–7) | 6 (4) | 4 (3–6) | 6 (6) | 4 (3–6) | 5 (6) | 4 (2–6) |
Spain | 5 (2) | 5 (3–6) | 4 (2) | 3 (3–6) | 5 (2) | 5 (3–6) | 4 (2) | 3 (3–6) |
UK | 6 (5) | 4 (2–8) | 5 (5) | 3 (2–6) | 5 (4) | 4 (3–8) | 6 (5) | 4 (3–7) |
Across countries | 5 (4) | 4 (2–6) | 4 (4) | 3 (2–5) | 5 (4) | 4 (3–6) | 5 (5) | 3 (2–5) |